Year: 2020

Nanox to Feature Nanox.ARC Digital X-Ray Technology in a Live Demonstration at the 2020 Radiology Society of North America Virtual Annual Meeting

Written by Customer Service on November 25, 2020. Posted in Public Companies.

NEVE ILAN, Israel, Nov. 25, 2020 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that the Company will host a live demonstration that will showcase the Nanox digital x-ray source tube and a range of 2D and 3D imaging applications performed by the Nanox.ARC at the 2020 Radiology Society of North America Virtual Annual Meeting. The live event will take place at the Nanox RSNA virtual booth on Thursday, December 3, 2020 at 11:00am E.T. An investor webinar will follow the live event on Thursday, December 3, 2020 at 2:00pm E.T.The investor webinar will feature a replay of the recorded RSNA live steam and presentations of clinical applications of the Nanox.ARC system by well-known radiologists and their views of how they believe it will...

Novo Provides Update on Partial Sale of Blue Spec Project

Written by Customer Service on November 25, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 25, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO & NVO.WT; OTCQX: NSRPF) is providing an update on the previously announced sale (the “Transaction”) of a portion of its Blue Spec project comprising mining leases 46/115 and 46/244 and related mining information (the “Subject Blue Spec Tenements”) in Western Australia to ASX-listed Calidus Resources Limited (“Calidus”) (please see the Company’s news release dated September 21, 2020 for further details). The Company has executed an amended terms sheet (the “Amended Terms Sheet”) and agreed to a revised transaction structure and payment schedule with Calidus as follows:Calidus will pay A$2.5 million to the Company by November 30, 2020 in exchange for a 10% interest in the Subject Blue Spec Tenements;Calidus...

Pulse Oximeters Market to Expand at 6.7% and to Reach US$ 2,657.6 Million by 2025; SMEs may Benefit from Increasing Device Approvals, says Fortune Business Insights

Written by Customer Service on November 25, 2020. Posted in Mergers And Acquisitions.

Pune, India, Nov. 25, 2020 (GLOBE NEWSWIRE) — The global pulse oximeters market is likely to grow in the coming years due to increasing usage clearances from the Food and Drug Administration (FDA). The market is likely to reach US$ 2,657.6 Mn by the end of 2025. Fortune Business Insights states that the market was valued at US$ 1,587.3 Mn in 2017 and will exhibit a CAGR of 6.7% in the forecast period. North America generated revenue of US$ 604.5 Mn in 2017 and is expected to dominate the market throughout the forecast period. Higher adoption of pulse oximeters and higher awareness amongst patients and caretakers are responsible for the higher share of North America in the global pulse oximeters market.Key Industry Developments:In April 2019, the sleep and respiratory division of Koninklijke Philips N.V., Philips Respironics, transferred...

Fronsac Announces the Closing of Its Fully-Subscribed Public Offering of Units and the Exercise by the Agents of the Over-Allotment Option in Full

Written by Customer Service on November 25, 2020. Posted in Public Companies.

Not for Distribution to United States Newswire Services or for Dissemination in the United StatesMONTREAL, Nov. 25, 2020 (GLOBE NEWSWIRE) — (TSX-V: FRO.UN) Fronsac Real Estate Investment Trust (the “REIT” or “Fronsac”) is pleased to announce that it has closed its previously-announced public offering (the “Offering”) of units of Fronsac (the “Units”).Under the Offering, an aggregate of 2,653,846 Units were issued and sold, including the exercise in full by the Agents (as defined below) of their over-allotment option to purchase up to 346,154 additional Units. The Units were issued and sold at a price of $6.50 per Unit for aggregate gross proceeds of $17,249,999. The Offering was made through a syndicate of agents co-led by Paradigm Capital Inc. and Canaccord Genuity Corp., acting as joint bookrunners, and including Desjardins Securities...

Fronsac annonce la clôture de son placement public entièrement souscrit de parts et l’exercice intégral de l’option de surallocation par les placeurs pour compte

Written by Customer Service on November 25, 2020. Posted in Public Companies.

Ne doit pas être distribué aux agences de transmission américaines ni diffusé aux ÉtatsUnisMONTRÉAL, 25 nov. 2020 (GLOBE NEWSWIRE) — (TSX-V : FRO.UN) Fiducie de placement immobilier Fronsac (la « FPI » ou « Fronsac ») est heureuse d’annoncer la clôture du placement public précédemment annoncé (le « Placement ») de ses parts (les « Parts »).Dans le cadre du Placement, 2 653 846 Parts ont été émises et vendues au total, ce qui inclut l’exercice intégral par les Placeurs pour compte (au sens attribué à ce terme ciaprès) de leur option de surallocation leur permettant d’acheter jusqu’à 346 154 Parts supplémentaires. Les Parts ont été émises et vendues au prix de 6,50 $ par Part, pour un produit brut total de 17 249 999 $. Le Placement a été effectué par l’entremise d’un syndicat de placeurs codirigé par Paradigm Capital Inc. et Corporation...

ARHT Media’s Strategic Partners Order Six HoloPresence™ Displays for Universities in China as Part of 5G Activations

Written by Customer Service on November 25, 2020. Posted in Public Companies.

TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV:ART), the global leader in the development, production and distribution of high-quality, low latency hologram and digital content, is pleased to announce that through a strategic partnership with a leading supplier of educational smart boards and one of China’s leading telecommunication companies they have received orders for six HoloPresenceTM Display systems that are to be deployed at universities across China in the fourth quarter of 2020.Seeking to take advantage of the increased data transmission speeds of 5G technology, the universities in China will have the ability to share subject matter expertise using ARHT Media’s HoloPresenceTM Technology as well as beam-in guest lecturers and instructors to their...

AgraFlora Organics Receives Analytical Equipment for its Winnipeg Edibles Manufacturing Facility

Written by Customer Service on November 25, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 25, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that it has acquired High Performance Liquid Chromatography (“HPLC”) equipment for AgraFlora’s 51,000-Square-foot fully-automated edibles manufacturing facility in Winnipeg, Manitoba (the “Edibles Facility”).The addition of an Agilent HPLC driven analytical testing platform at the Edibles Facility will allow AgraFlora to rapidly develop and launch new edibles products which have been formulated from the Company’s previously announced (See press release dated August 27, 2020) Research and Development (“R&D”) trials through the Company’s Health Canada R&D license.James Fletcher, EIC Co-Founder and Operational Manager stated,...

Sparton Resources Inc. Signs Memorandum of Understanding with Matachewan First Nation

Written by Customer Service on November 25, 2020. Posted in Public Companies.

TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) — Sparton Resources Inc. (TSXV.SRI) (“Sparton” or the “Company“) is pleased to announce that it has signed, effective November 17, 2020 a Memorandum of Understanding (“MOU”) with the Matachewan First Nation (“MFN”) related to its exploration program activities on the Sir Harry Oakes Gold Project near Matachewan, Ontario.MFN is a signatory to Treaty No. 9 and holds inherent aboriginal and treaty rights to and over their traditional territory, which includes the Mining Leases and claims held by Sparton and referred to as the Sir Harry Oakes Project. The MOU recognizes these rights and provides for a mutually beneficial and cooperative relationship between the parties.MOU TERMSThe MOU, among other things, contemplates the possibility of an Investment Benefit Agreement...

Standard Uranium Plans Phase II Drill Program at its Flagship Davidson River Project Based on Successful Phase I Drilling Results

Written by Customer Service on November 25, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 25, 2020 (GLOBE NEWSWIRE) — Standard Uranium Ltd. (“Standard Uranium” or the “Company”) (TSX-V: STND) (Frankfurt: FWB:9SU) is pleased to announce the company is planning a phase II diamond drilling program at its flagship 25,886 hectare Davidson River Uranium Project (the “Project”). The Project is located in the Southwest Athabasca Uranium District of the Athabasca Basin, Saskatchewan, and encapsulates the inferred trend that hosts Fission Uranium’s Triple R deposit and NexGen’s Arrow deposit, over an area 25 km to 30 km to the west of those deposits. The Phase II program is set to begin in early 2021, dependent on COVID-19. The Company is also pleased to announce a summary of results from the Phase I summer 2020 diamond drilling program at the Project.Jon Bey, President, CEO and Chairman commented:...

Sarepta Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference

Written by Customer Service on November 25, 2020. Posted in Public Companies.

CAMBRIDGE, Mass., Nov. 25, 2020 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Virtual Conference on Wednesday, Dec. 2, 2020 at 3:30 p.m. E.T.The presentation will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta’s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.About Sarepta TherapeuticsAt Sarepta, we are leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living...

Year: 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals